In Genotoxicity testing, to assay for genotoxic molecules, researchers assay for DNA damage in cells exposed to the toxic substrates. Techniques like in vitro and in vivo Toxicology Tests, Ames Assay and Comet Assay have been developed to determine the chemical’s potential to cause DNA damage that may lead to cancer. Genotoxicity tests are designed to detect drugs which can cause genetic damage directly or indirectly by various mechanisms of action. Compounds which are identified as genotoxic in these tests have the ability to be human carcinogens and ultimately may induce cancer and heritable defects. Genotoxicity testing of new chemical entities is an integral part and is a regulatory requirement prior to the approval of new drugs, in Drug Development process. Late stage failures can be reduced by identifying genotoxicity at an early stage in Drug Discovery rather than during regulatory assessment.


  • Genotoxicity testing
  • Genotoxicity and mutagenicity
  • Pharmacogenetics & pharmacogenomics
  • In vitro and in vivo testing
  • Genotoxic drugs

Related Conference of Genotoxicity

June 02-03, 2022


Manila, Philippines

Genotoxicity Conference Speakers

Recommended Sessions

Related Journals

Are you interested in